다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

EW Edwards Lifesciences Corp

65.81

-0.89 (-1.33%)

시간외 거래

최종 업데이트: 07:30:00

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares on this filing were acquired and paid for between 05/14/2015 - 05/12/2020.

Date of Notice

11/05/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

05/01/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Larry L Wood

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Edwards Lifesciences (NYSE:EW)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024

Edwards Lifesciences 차트를 더 보려면 여기를 클릭.

Edwards Lifesciences (NYSE:EW)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024

Edwards Lifesciences 차트를 더 보려면 여기를 클릭.

Edwards Lifesciences Corp News

The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
0년 11월 11일, 2024 (2 일 전) • PR Newswire (US)

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW
0년 7월 11일, 2024 (6 일 전) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
0년 7월 11일, 2024 (6 일 전) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
0년 6월 11일, 2024 (1 주 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 6월 11일, 2024 (1 주 전) • Edgar (US Regulatory)

The Gross Law Firm Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
0년 4월 11일, 2024 (1 주 전) • PR Newswire (US)

Shareholders that lost money on Edwards Lifesciences Corporation(EW) should contact The Gross Law Firm about pending Class Action - EW
0년 31월 10일, 2024 (2 주 전) • PR Newswire (US)

Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
0년 31월 10일, 2024 (2 주 전) • Business Wire

TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
0년 31월 10일, 2024 (2 주 전) • Business Wire

Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
0년 29월 10일, 2024 (2 주 전) • Business Wire

The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline
0년 28월 10일, 2024 (2 주 전) • PR Newswire (US)

Form 8-K - Current report
0년 25월 10일, 2024 (3 주 전) • Edgar (US Regulatory)

More Edwards Lifesciences Corp News Articles

US Dollar vs Euro

BNP Paribas (QX)

Financial Select Sector

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관